Article

In Vitro Combinatorial Activity of Direct Acting Antivirals and Monoclonal Antibodies against the Ancestral B.1 and BQ.1.1 SARS-CoV-2 Viral Variants

2024-01-03

Abstract excerpt

Combination antiviral therapy may be helpful in the treatment of SARS-CoV-2 infection, however no clinical trial data are available and combined use of direct acting antivirals (DAA) and monoclonal antibodies (mAb) has been reported only anecdotally. To assess the cooperative effects of dual drug combinations in vitro, we used a VERO E6 cell based in vitro system with the ancestral B.1 or the highly divergent BQ.1...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 418d097e-762c-53f9-8ce0-eb7f3ad9e758
DOI: 10.20944/preprints202401.0279.v1

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

In Vitro Combinatorial Activity of Direct Acting Antivirals and Monoclonal Antibodies against the Ancestral B.1 and BQ.1.1 SARS-CoV-2 Viral VariantsDOI 10.20944/preprints202401.0279.v1Read

The Combination of Molnupiravir with Nirmatrelvir or GC376 Has a Synergic Role in the Inhibition of SARS-CoV-2 Replication In VitroSemantic proximity Read

Identification of novel antiviral drug combinations in vitro and tracking their developmentSemantic proximity Read

Synergistic Antiviral Activity of European Black Elderberry Fruit Extract and Quinine Against SARS-CoV-2 and Influenza A VirusSemantic proximity Read

In Vitro Efficacy of Antivirals and Monoclonal Antibodies against SARS-CoV-2 Omicron Lineages XBB.1.9.1, XBB.1.9.3, XBB.1.5, XBB.1.16, XBB.2.4, BQ.1.1.45, CH.1.1, and CL.1Semantic proximity Read

The IDentif.AI 2.0 Pandemic Readiness Platform: Rapid Prioritization of Optimized COVID-19 Combination Therapy RegimensSemantic proximity Read

Synergistic interactions of repurposed drugs that inhibit Nsp1, a major virulence factor for COVID-19Semantic proximity Read

Mathematical modeling of multi-drugs therapy: a challenge for determining the optimal combinations of antiviral drugs.Semantic proximity Read

Synergism of interferon-beta with antiviral drugs against SARS-CoV-2 variantsSemantic proximity Read

Synergism between remdesivir and ribavirin leads to SARS‐CoV‐2 extinction in cell cultureSemantic proximity Read

Assessment of combined antiviral drug treatment against selected α-, β-, and γ-herpesvirusesSemantic proximity Read

Remdesivir-Nirmatrelvir Combination: In Vitro Activity and a Case ReportSemantic proximity Read

Combinations of Host- and Virus-Targeting Antiviral Drugs Confer Synergistic Suppression of SARS-CoV-2Semantic proximity Read